Deutsche Bank Comments on Bristol-Myers Squibb (BMY) Opdivo News; Analyst Says Merck (MRK) Not Guaranteed to be Alone in Front-Line Setting
Go back to Deutsche Bank Comments on Bristol-Myers Squibb (BMY) Opdivo News; Analyst Says Merck (MRK) Not Guaranteed to be Alone in Front-Line SettingBristol-Myers Squibb (NYSE: BMY) | Delayed: 48.99 -0.15 (0.31%) | |||||
---|---|---|---|---|---|---|
Previous Close | $49.14 | 52 Week High | $77.12 | |||
Open | $49.16 | 52 Week Low | $49.03 | |||
Day High | $49.47 | P/E | 31.81 | |||
Day Low | $48.96 | EPS | $1.54 | |||
Volume | 9,135,391 |
Merck & Co. (NYSE: MRK) | Delayed: 126.88 -0.06 (0.05%) | |||||
---|---|---|---|---|---|---|
Previous Close | $126.94 | 52 Week High | $65.46 | |||
Open | $128.10 | 52 Week Low | $47.97 | |||
Day High | $128.10 | P/E | 86.31 | |||
Day Low | $126.74 | EPS | $1.47 | |||
Volume | 7,494,139 |